Health Care
Overweight
Buy Into Managed Health Care Weakness…
Buy Into Managed Health Care Weakness…
Highlights Portfolio Strategy Yield curve dynamics, higher oil prices, recovering balance sheets, and compelling valuations and technicals all suggest that energy stocks will burst higher in the coming months. Melting medical cost inflation, BCA’s rising interest rate expectations along…
Underweight In last month’s downgrade of the S&P pharma index to underweight, we highlighted that headwinds to drug prices would weigh on the sector’s earnings profile.1 This week’s CPI report confirmed this negative pricing view with prescription drugs falling into outright deflation; in…
A Healthier GE With Less Healthcare…
Pharma's Pain
Pharma's…
Overweight S&P Biotech…
...Pharmas Pain
...…
Biotechs Gain Is...…
Highlights Portfolio Strategy The path of least resistance is higher for the broad equity market on the back of a reflationary impulse and a less dogmatic Fed. Now that the SPX forward EPS bar has been lowered to the ground, upward surprises loom, especially if the third catalyst we have been…